The hexagonal rhabdophane-type GdPO(4) hydrate (GdPO(4).nH(2)O) was synthesized via a simple hydrothermal process. The size and morphology of the products can be tunable by adjusting the pH of reaction systems through the addition of aqueous NaOH. The nanorods with a width of 50-100 nm and a length of about 1 microm were obtained in the absence of NaOH (pH = 2), while a significant reduction of size (width: approximately 10 nm, length: approximately 50 nm) was observed for the product synthesized in the presence of NaOH (pH = 10). Surprisingly, the small-sized product exhibits a remarkably enhanced photoluminescence quantum yield and long excited state lifetime in comparison with those of the large-sized product. This abnormal luminescence phenomenon is discussed and explained. The EDS and XPS measurements revealed the presence of Na(+) in the small-sized samples. These Na(+) cations were probably bonded to the surface O(2-) dangling bonds, which thus reduces the number of surface defects that usually serve as the nonradiative energy transfer center channels. A considerable reduction of surface defect centers results in the increase of the emission efficiency and excited state lifetime in a small-sized sample. Obviously, the controlled synthesis of rare-earth-doped nanoparticles with a small size, but with relatively strong luminescence, is significant for their applications in the areas of technologies including optoelectronics, sensing and bioimaging.
No takes yet. Share an insight, caveat, or question.
Lü et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: